Skip to main content

Change location

You are currently on the USA (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
  • Product Security
  • Sign up
    • USA (English)
  • We are Bracco Diagnostics
    We are Bracco

    Welcome to a World of contrasts

    • Bracco at a glance
    • Past, present, future
    • Our Foundation
    • Our business
  • Our portfolio

    To order products go to myorders.bracco.com

    • X-ray & CT
      • Products

        • ISOVUE and Imaging Bulk Package
        • GASTROGRAFIN
        • READI-CAT 2 SMOOTHIE
        • READI-CAT 2
        • TAGITOL V
      • Fluoroscopy

        • VARIBAR
        • CYSTOGRAFIN
        • CYSTOGRAFIN-DILUTE
        • E-Z-DISK
        • E-Z-GAS II
        • E-Z-HD
        • E-Z-PAQUE
        • ENTERO VU
        • GASTROGRAFIN
        • Liquid E-Z-PAQUE
      • Myelography

        • ISOVUE-M 200/300
      • Medical devices

        • Empower CTA+
        • NEXO
        • PROTOCO2L TOUCH
    • MRI
      • Contrast agents

        • VUEWAY
        • MultiHance
        • ProHance
      • Medical Devices

        • Max 3
        • EmpowerMR
      • AI

        • AiMIFY
      • Other

        • CitraClear™
    • Ultrasound
      • Contrast agents

        • LUMASON
    • Nuclear medicine
      • Products

        • CardioGen-82
        • HeartSee
        • Kinevac
        • Choletec
    • Cardiology
      • Contrast agents

        • CardioGen-82
        • Lumason
        • ISOVUE
        • ACIST CVi
        • Heartsee
    • Digital solutions
    • Reimbursement
    • Oncology
  • Bracco innovation—the driving force behind everything we do, building upon our unique culture of research and discovery.
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage
  • Knowledge header
    Knowledge

    Current activities and future opportunities

    • Educational programs
    • Partnerships and sponsorships
    • Events
  • bracco sustainability report
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Article
Bracco Highlights at RSNA 2023 Join Bracco at RSNA 2023 to explore our latest innovations in medical imaging, including AI-driven tools and advanced contrast agents. 
RSNA 2023
Article
Data Reinforcing Efficacy and Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions Published in Radiology
Vueway Gadopiclenol
Article
Data Reinforcing Efficacy and Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions Published in Radiology The results of the multicenter, international PROMISE clinical trial demonstrate that gadopiclenol provides similar lesion visualization and contrast enhancement at a gadolinium dose of 0.05 mmol/kg versus a full dose of gadobutrol (0.1 mmol/kg).
Vueway Gadopiclenol
Article
Funding the Future of Radiology¹ With an over $1.8 million investment in radiology research, Bracco Diagnostics Inc. actively supports the advancement of the field by ensuring that 34 early-career radiological investigators have access to much-needed funding.
No image available
Article
Bracco: Driving the Future of Radiology Innovation Explore how Bracco's $1.8M investment in radiology innovation resulted in 59 manuscripts, six patents, two startup businesses, and additional grant funding.
No image available
Article
Recognizing Radiology Leaders of the Future Bracco celebrates 34 radiology professionals shaping the future of medical imaging through innovation, education, and collaboration worldwide.
No image available
Article
What AI Means for the Future of Medical Imaging Explore the role of AI in transforming medical imaging, improving diagnostic accuracy, and streamlining radiology workflows for better patient outcomes.
Symposium on the future of the Healthcare Industry and Diagnostic Imaging in the era of Artificial Intelligence
Article
Bracco Imaging and Subtle Medical Global Agreement Bracco signs global agreement with Subtle Medical to integrate AI-driven image enhancement into diagnostic workflows for improved accuracy.
BRACCO IMAGING S.p.A. ANNOUNCES GLOBAL AGREEMENT WITH SUBTLE MEDICAL, Inc.
Article
Vueway® Earns Positive CHMP Opinion for MRI Contrast Learn about Vueway® (gadopiclenol) receiving a positive CHMP opinion, moving closer to full European approval for advanced MRI contrast imaging.
Bracco Joined the United Nations Global Compact
Article
Bracco Spin: 20 Years of Innovation Bracco commemorates two decades of success with Bracco Spin by announcing plans to expand production capacity.
Diana Bracco riceve la cittadinanza onoraria di Torviscosa
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182